MetaCap

Citius Oncology Inc. Company Profile

NASDAQ: CTORHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.5035-0.0619 (-10.95%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Citius Oncology at a glance

Citius Oncology Inc. (NASDAQ: CTOR) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Cranford, NJ. Citius Oncology is led by Mr. Leonard L. Mazur. The company's shares have traded publicly since 2022.

At a market capitalization of $52.6 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001851484, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Citius Oncology do?

Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Leonard-Meron Biosciences, Inc.

Business description based on the company's public filings.

Company information

Legal name
Citius Oncology Inc.
Ticker
NASDAQ: CTOR
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Leonard L. Mazur
Headquarters
11 Commerce Drive, Cranford, NJ, United States
Phone
908 967 6677
IPO year
2022
Market cap
$52.57M
SEC CIK
0001851484
Latest annual report
10-K · Dec 23, 2025

Companies similar to Citius Oncology

CTOR peer companies
CompanyPrice% ChgMarket capCompare
LFVNLifevantage Corporation4.15-15.13%$52.63Mvs CTOR
XBITXBiotech Inc.1.73+2.98%$52.74Mvs CTOR
XLOXilio Therapeutics Inc.7.56-1.11%$53.40Mvs CTOR
ALDXAldeyra Therapeutics Inc.0.84+16.39%$50.70Mvs CTOR
CLNNClene Inc.3.52+0.57%$50.69Mvs CTOR
BOLDBoundless Bio Inc.2.32-2.52%$54.78Mvs CTOR
AZRAzora Therapeutics Inc.3.85-0.52%$55.00Mvs CTOR
ACRVAcrivon Therapeutics Inc.1.15-17.86%$49.35Mvs CTOR

Related